Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
LIPONEXT

Developing new treatments for patients with kidney disease

MicroFluidX

Revolutionary platform for cell and gene therapy manufacturing

NANOGAP Therapeutics

Developing a completely novel class of therapeutics

Neurocentrx Pharma

Aiming to provide existing approved drugs in new and improved formats for patients - through reformulation, reindication, clinical development and product in-licensing

NSCI Therapeutics

Advancing cell-based therapies and biologics for retinal disease

OmniSpirant Therapeutics

Developing Regenerative Gene Therapies with the Potential to Transform Respiratory Medicine

OncoLize

Developing high performance oncology products for localized and slow delivery of drugs

OR Productivity

Designs and commercialises robots for use in minimal access medicine and surgery

OVO Manufacturing

Improving viral vaccine yield by 10-fold and reducing lead time without impacting regulatory compliance

Oxford Cancer Biomarkers

Have developed pioneering biomarker technology products that put each individual patient at the centre of cancer treatment

Oxford Endovascular

Developing metallic mesh tube devices to treat patients suffering from brain aneurysms

pHion Therapeutics

Dedicated to precise and efficient drug delivery using targeted nanoparticles